Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01771627 · ClinicalTrials.gov registry record · NA
Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers
A NA study, sponsored by Roswell Park Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT01771627 is a NA study that has completed, run by Roswell Park Cancer Institute. The registered enrollment target is 300 participants.
The verdict
NCT01771627, a NA study, has completed, sponsored by Roswell Park Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
This pilot clinical trial studies varenicline or nicotine patch in promoting smoking cessation among current smokers. Varenicline or nicotine patch may help people stop smoking
Interventions
- DRUG nicotine patch
- DRUG varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2012-10-22 |
| Est. Completion | 2015-08-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01771627
The ClinicalTrials.gov registry entry for NCT01771627 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Roswell Park Cancer Institute, which has 365 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which nicotine patch is the first listed.
NCT01771627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01771627 about?
NCT01771627 is a clinical study titled "Varenicline or Nicotine Patch in Promoting Smoking Cessation Among Current Smokers". This pilot clinical trial studies varenicline or nicotine patch in promoting smoking cessation among current smokers. Varenicline or nicotine patch may help people stop smoking
What is the current status of trial NCT01771627?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2012-10-22. Estimated completion is 2015-08-28.
What interventions are being tested in trial NCT01771627?
The interventions under investigation include: nicotine patch (DRUG), varenicline (DRUG).
Who is sponsoring clinical trial NCT01771627?
This trial is sponsored by Roswell Park Cancer Institute, which has 365 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.